Complications of Minor Cutaneous Surgery in Patients Under Anticoagulant Treatment
| Autor: | Orhan Babuccu, Cevdet Altinyazar, Mübin Hoşnuter, Berfu Babuccu, Eksal Kargi |
|---|---|
| Přispěvatelé: | Zonguldak Bülent Ecevit Üniversitesi |
| Rok vydání: | 2002 |
| Předmět: |
Adult
Male medicine.medical_specialty complications medicine.drug_class medicine.medical_treatment Dermatologic Surgical Procedures anticoagulant treatment Postoperative Complications medicine Humans Prospective Studies Prospective cohort study Aged Aged 80 and over Wound Healing Chemotherapy Aspirin business.industry Incidence (epidemiology) Anticoagulant Warfarin cutaneous surgery Anticoagulants Middle Aged Surgery Plastic surgery Female business Complication medicine.drug |
| Zdroj: | Aesthetic Plastic Surgery. 26:483-485 |
| ISSN: | 1432-5241 0364-216X |
| Popis: | WOS: 000181079800016 PubMed: 12621574 Anticoagulant use is common in the elderly population. The role of these medications in the postoperative period is not well defined. We designed a prospective study to evaluate the incidence of postoperative complications in patients taking aspirin and warfarin. A prospective study was performed on 102 patients undergoing minor cutaneous plastic surgery. The number of subjects using regular aspirin, warfarin, and that of the patients with no anticoagulant medication were 37, 21, and 44, respectively. Complications were defined as minor, moderate, or major based on predetermined criteries. Of patients taking warfarin, 57% had some complication, significantly more than complications in the control group. The number of major complications in the warfarin group was significantly higher than those of the control and aspirin groups (p = 0.02). Also, the total number of complications in the warfarin group was significantly higher than the control group, but there was no significant difference between aspirin and control groups (p > 0.05). Cutaneous surgery in patients who receive warfarin is associated with a risk of major complication, but this risk does not exist in the patients receiving chronic aspirin treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink